Affimed (AFMD) News Today $0.93 -0.03 (-3.33%) As of 10:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period StockNews.com Initiates Coverage on Affimed (NASDAQ:AFMD)May 5 at 1:31 AM | americanbankingnews.comAffimed Delays Filing of 2024 Yearly ReportMay 1, 2025 | tipranks.comAFM24 shows promise in advanced lung cancer treatmentApril 30, 2025 | investing.comAffimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual MeetingApril 29, 2025 | globenewswire.comAffimed (NASDAQ:AFMD) Receives $13.50 Consensus PT from BrokeragesApril 29, 2025 | americanbankingnews.comStockNews.com Begins Coverage on Affimed (NASDAQ:AFMD)April 25, 2025 | americanbankingnews.comAffimed Announces Acceptance of Three Abstracts for Presentation at the American Society for ...April 23, 2025 | gurufocus.comAffimed Announces Acceptance of Three Abstracts for Presentation at the American Society for ...April 23, 2025 | gurufocus.comAffimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual MeetingApril 23, 2025 | globenewswire.comAffimed receives Nasdaq notice of non-complianceApril 21, 2025 | markets.businessinsider.comAffimed Receives Nasdaq Deficiency Notice Over Low Share Price: Retail’s In Wait-And-Wait ModeApril 21, 2025 | msn.comAffimed Faces Nasdaq Delisting Risk Due to Share PriceApril 21, 2025 | tipranks.comAffimed (AFMD) Faces Nasdaq Delisting Risk Over Share PriceApril 21, 2025 | gurufocus.comAffimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price RequirementApril 21, 2025 | gurufocus.comAffimed (AFMD) Faces Nasdaq Delisting Risk Due to Low Share Price | AFMD Stock NewsApril 21, 2025 | gurufocus.comAffimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement | ...April 21, 2025 | gurufocus.comAffimed N.V. Receives Nasdaq Notification Regarding Minimum Bid Price ComplianceApril 21, 2025 | quiverquant.comAffimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price RequirementApril 21, 2025 | globenewswire.comAffimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual MeetingMarch 25, 2025 | globenewswire.comAffimed to Present at the Leerink Partners Global Healthcare Conference 2025March 3, 2025 | globenewswire.com683 Capital Management, LLC Reduces Stake in Affimed NVFebruary 14, 2025 | gurufocus.comAnalyst revises Affimed Therapeutics stock price target amid AFM24 trial progressionDecember 20, 2024 | uk.investing.comAffimed price target lowered to $11 from $15 at Wells FargoDecember 19, 2024 | markets.businessinsider.comAffimed (AFMD) Gets a Buy from Truist FinancialDecember 19, 2024 | markets.businessinsider.comAffimed’s AFM24/atezolizumab combination shows positive results in NSCLC trialDecember 18, 2024 | markets.businessinsider.comAffimed price target lowered to $7 from $10 at H.C. WainwrightDecember 18, 2024 | tipranks.comAffimed’s Promising Clinical Update on NSCLC TreatmentDecember 18, 2024 | markets.businessinsider.comAffimed Shares Fall 32% on Clinical UpdateDecember 18, 2024 | finance.yahoo.comAffimed stock plunges 23% on AFM24 study updateDecember 18, 2024 | msn.comAffimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)December 17, 2024 | markets.businessinsider.comAffimed Reports Positive Data From AFM24-102 Trial In Heavily Pretreated NSCLC PatientsDecember 17, 2024 | markets.businessinsider.comAffimed price target lowered to $15 from $20 at Wells FargoDecember 12, 2024 | tipranks.comAffimed reports ‘promising’ Phase 1 efficacy, safety data for AFM28December 9, 2024 | tipranks.comAffimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)December 9, 2024 | globenewswire.comAffimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung CancerDecember 9, 2024 | globenewswire.comAffimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) PatientsDecember 8, 2024 | globenewswire.comAffimed Announces RMAT Designation To Combination Therapy Of ICE Acimtamig And AB101December 5, 2024 | markets.businessinsider.comAffimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)December 5, 2024 | globenewswire.comIs Affimed N.V. (AFMD) the Best German Stock to Buy Now?November 19, 2024 | msn.comCantor Fitzgerald Reiterates "Overweight" Rating for Affimed (NASDAQ:AFMD)Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Affimed in a report on Tuesday.November 19, 2024 | marketbeat.comPromising Clinical Developments and Data Catalysts Position Affimed for Strong Future ProspectsNovember 17, 2024 | markets.businessinsider.comAffimed price target lowered to $4 from $5 at StifelNovember 17, 2024 | markets.businessinsider.comStifel Nicolaus Cuts Affimed (NASDAQ:AFMD) Price Target to $4.00Stifel Nicolaus cut their target price on Affimed from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Friday.November 15, 2024 | marketbeat.comAffimed N.V. (NASDAQ:AFMD) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | insidermonkey.comHC Wainwright Reiterates Buy Rating for Affimed (NASDAQ:AFMD)HC Wainwright reiterated a "buy" rating and set a $10.00 price objective on shares of Affimed in a report on Friday.November 15, 2024 | marketbeat.comAffimed Faces Growing Losses Amid Financial StrugglesNovember 15, 2024 | markets.businessinsider.comAffimed N.V. (AFMD) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comAffimed Reports Third Quarter 2024 Financial Results & Business UpdateNovember 14, 2024 | globenewswire.comA Look Ahead: Affimed's Earnings ForecastNovember 13, 2024 | benzinga.comAffimed Q3 2024 Earnings PreviewNovember 13, 2024 | msn.com Get Affimed News Delivered to You Automatically Sign up to receive the latest news and ratings for AFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address AFMD Media Mentions By Week AFMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AFMD News Sentiment▼0.120.73▲Average Medical News Sentiment AFMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AFMD Articles This Week▼51▲AFMD Articles Average Week Get Affimed News Delivered to You Automatically Sign up to receive the latest news and ratings for AFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABOS News Today INZY News Today IKNA News Today ACHL News Today ADVM News Today ASRT News Today ARTV News Today SKYE News Today CYCC News Today RPTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AFMD) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Affimed Please log in to your account or sign up in order to add this asset to your watchlist. Share Affimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
